Gentian Diagnostics ASA Logo

Gentian Diagnostics ASA

GENT | OL

Overview

Corporate Details

ISIN(s):
NO0010748866
LEI:
5967007LIEEXZXHNM861
Country:
Norway
Address:
Bjørnåsveien 5, 1596 Moss
Sector:
Health Care
Industry:
Biotechnology

Description

Gentian is a Norwegian IVD company that specialises in developing and manufacturing turbidimetric assays that enable clinical lab professionals to achieve greater operational efficiency, thus providing faster patient results to clinicians. The current portfolio and pipeline of diagnostic reagents span areas of kidney disease, cardiac disease, inflammation, infection and veterinary medicine. By leveraging both our expertise in Particle-Enhanced Turbidimetric Immunoassays (PETIA) and proprietary nanoparticle technology, we develop immunoassays that enable users to transition from traditional low volume immunology platforms to fully automated clinical chemistry instruments. The typical Gentian customer enjoys shorter turnaround times, streamlined workflows and improved cost efficiency.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-02 16:34
Major Shareholding Notification
Flaggemelding Gentian Diagnostics ASA
Norwegian 495 bytes
2025-05-23 09:39
Major Shareholding Notification
Disclosure of shareholding
English 986 bytes
2025-05-22 08:47
Directors' Dealings
Disclosure of large shareholding
English 893 bytes
2025-05-08 08:00
Directors' Dealings
Mandatory notification of trade
Norwegian 131.6 KB
2025-05-08 08:00
Directors' Dealings
Mandatory notification of trade
English 1.4 KB
2025-05-07 06:07
Regulatory News Service
Gentian Diagnostics: Ex dividend NOK 0.40 today
Norwegian 708 bytes
2025-05-07 06:00
Regulatory News Service
Gentian Diagnostics: First quarter 2025 report
English 2.1 MB
2025-05-07 06:00
Earnings Release
Gentian Diagnostics: First quarter 2025 report
English 750.7 KB
2025-05-07 06:00
Earnings Release
Gentian Diagnostics: First quarter 2025 report
English 2.7 KB
2025-05-06 10:14
Regulatory News Service
Gentian Diagnostics: Minutes from Annual General Meeting
English 7.0 MB
2025-05-06 10:14
Regulatory News Service
Gentian Diagnostics: Minutes from Annual General Meeting
English 724 bytes
2025-04-30 08:10
Regulatory News Service
Gentian Diagnostics: Invitation to presentation of first quarter results
English 726 bytes
2025-04-11 10:56
Regulatory News Service
Gentian Diagnostics: Notice of annual general meeting
English 1.5 MB
2025-04-11 10:56
Regulatory News Service
Gentian Diagnostics: Notice of annual general meeting
English 776 bytes
2025-04-07 12:23
Directors' Dealings
Mandatory notification of trade
English 123.1 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GenSight Biologics S.A. Logo GenSight Biologics S.A. France SIGHT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO
Herantis Pharma Oyj Logo Herantis Pharma Oyj Finland HRTIS